Cactus Peptides
Tirzepatide
Finnrick tested 2 samples of Tirzepatide (GLP-1 and GIP agonist) from Cactus Peptides on 15 Jun 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Cactuspeptides.comFinnrick verified this link on 1 Jun 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Cactus Peptides
Samples are tested in commercial labs
Tests Count
Scores
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 15 Jun 2026 | View | 15mg | 12.3mg | -18.0% | 99.90% | below LOQ | M167 | Black label / Silver crimp / Yellow cap | Lab E | Vendor | |
| 15 Jun 2026 | View | 15mg | 12.5mg | -16.7% | 99.90% | below LOQ | M167 | Black label / Silver crimp / Yellow cap | Lab E | Vendor | |
Launch with Finnrick
Some of the samples listed on this page were submitted by their vendor, as part of the Launch with Finnrick vendor support program.
The program is designed to help vendors get listed on the Finnrick web site while protecting the integrity of our rating system.
The vendor submitted four samples per product, two of which were tested by Finnrick for identity, purity and quantity according to our usual process. The vials were anonymized before being sent to the testing lab.